Ballast Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
Ballast Asset Management's COLL Position: Q3 2026 in Review
Ballast Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 3% in Q3 2026, selling an estimated $97.4K and leaving 108,775 shares worth $2.37M. The position accounts for 1.03% of the portfolio, ranked #48.
Ballast Asset Management first reported a position in COLL in Q2 2025 and has held it in 6 quarters since. The position peaked at $5.11M in Q4 2025. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- Ballast Asset Management held 108,775 shares of Collegium Pharmaceutical worth $2.37M as of Q3 2026.
- Ballast Asset Management sold 3,336 Collegium Pharmaceutical shares in Q3 2026, an estimated $97.4K.
- Collegium Pharmaceutical made up 1.03% of Ballast Asset Management's portfolio in Q3 2026, its #48 holding.
- Ballast Asset Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
- Ballast Asset Management's Collegium Pharmaceutical position peaked at $5.11M in Q4 2025.
- 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on Ballast Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.